Olema Pharmaceuticals director sells shares worth $147,955 By Investing.com
SAN FRANCISCO—Harmon Cyrus, a director at Olema Prescription drugs, Inc. (NASDAQ:OLMA), a $493.56 million market cap biotech firm, lately executed ...
Monday, March 23, 2026
Tag: Olema
RECOMMENDED
Agent Control Planes Still Need A Robust Standards Stack
This submit is a follow-up to my earlier announcement of our protection of the agent management planes market. Analysis questionnaires...
Copyright © 2024 PWC.